Article
Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences - 15 Sept 2018
Xu Shansen, Chen Yanan, Zhao Mingming, Guo Yingjie, Wang Zhanyou, Zhao Limei
Abstract excerpt
Valproic acid (VPA) is a first-line anti-epileptic drug that is used in the treatment of generalized and partial seizures. Gene variants had been proved to influence the pharmacokinetics (PK) of VPA and contribute to its inter-individual variability (IIV). The aim of this study was to systematically investigate the effects of candidate gene variants (CYPs, UGTs, ABC transporters, and nuclear receptors) on VPA PK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
